<scp>MicroRNA</scp>‐338‐3p as a therapeutic target in cardiac fibrosis through <scp>FGFR2</scp> suppression
Cheng Huang(Army Medical University), Min Wu(Guangdong Academy of Medical Sciences), Jindong Xu(Beijing YouAn Hospital), Jianjun Lu(Sun Yat-sen University), Zhe Feng(Chinese PLA General Hospital), Wuxia Ma(Guangdong Academy of Medical Sciences), Rui Wang(Brigham and Women's Hospital), Yongli He(Guangdong General Hospital), Yueheng Wu(Sun Yat-sen University), Zejia Wu(Guangdong Academy of Medical Sciences)
Cited by 22
Related Papers
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Downregulation of Connexin 43 Expression by High Glucose Induces Senescence in Glomerular Mesangial Cells
|Journal of the American Society of Nephrology|2006|71
CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia
|Arteriosclerosis Thrombosis and Vascular Biology|2018|51
Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction
|Redox Biology|2019|49
Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility
|Translational research|2012|41